Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type 2 diabetes: update on therapy

C Kappel1, D G Dills

  • 1Section of Endocrinology, University of Wisconsin, Madison 53792, USA.

Comprehensive Therapy
|July 21, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical experience of patients referred to a multidisciplinary cardio-oncology clinic: an observational cohort study.

Current oncology (Toronto, Ont.)·2019
Same author

Contactless determination of nuclear compressibility using 3D image- and model-based analysis of drug-induced cellular deformation.

Journal of microscopy·2010
Same author

Successful control of methicillin-resistant Staphylococcus aureus in a spinal cord injury center: a 10-year prospective study including molecular typing.

Spinal cord·2007
Same author

New aspects of insulin therapy in type 1 and type 2 diabetes.

Current diabetes reports·2003
Same author

Single-stranded conformational polymorphism analysis of the mitochondrial glycerol phosphate dehydrogenase gene in NIDDM.

Diabetes·1997
Same author

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·1996
Same journal

Heparin-induced thrombocytopenia and thrombosis.

Comprehensive therapy·2011
Same journal

Antiplatelet therapy in cardiovascular disease.

Comprehensive therapy·2011
Same journal

Genetics of cardiovascular disease.

Comprehensive therapy·2011
Same journal

Septic renal vein thrombosis complicated by septic pulmonary embolism.

Comprehensive therapy·2011
Same journal

Gout and hyperuricemia.

Comprehensive therapy·2011
Same journal

Problems with computerized health records.

Comprehensive therapy·2011
See all related articles

Type 2 diabetes is a widespread condition affecting millions. Primary care providers must stay updated on diverse treatment options like diet, exercise, oral medications, and insulin therapy.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Primary Care Medicine

Background:

  • Type 2 diabetes mellitus (T2DM) is a prevalent chronic metabolic disorder.
  • Affects an estimated 12 million individuals in the United States.
  • Characterized by hyperglycemia due to insulin resistance and relative insulin deficiency.

Purpose of the Study:

  • To inform primary care providers about the expanding therapeutic landscape for T2DM.
  • To emphasize the importance of staying current with treatment advancements.
  • To provide an overview of current management strategies.

Main Methods:

  • Review of current clinical guidelines and therapeutic options for T2DM.
  • Synthesis of information on lifestyle modifications and pharmacological interventions.

Related Experiment Videos

  • Focus on practical application in primary care settings.

    • Main Results:

    • A wide array of treatment modalities are available for T2DM management.
    • Treatment strategies encompass lifestyle interventions (diet, exercise) and pharmacotherapy (oral agents, insulin).
    • Individualized treatment plans are crucial for optimal patient outcomes.

    Conclusions:

    • Primary care providers play a vital role in managing T2DM.
    • Awareness of evolving treatment options is essential for effective patient care.
    • Comprehensive management involving lifestyle and medication is key to controlling T2DM.